FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

8 results

mycophenolic acid
(Mycophenolic Acid)
Accord Healthcare Inc.
Usage: Mycophenolic acid delayed release tablets are indicated for preventing organ rejection in adult and pediatric kidney transplant patients, used alongside cyclosporine and corticosteroids. They should not be interchanged with mycophenolate mofetil without medical supervision due to differing absorption rates.
mycophenolic acid
(mycophenolic acid)
CONCORD BIOTECH LIMITED
Usage: Mycophenolic acid delayed-release tablets are indicated for preventing organ rejection in kidney transplant patients aged 5 and older, used alongside cyclosporine and corticosteroids. It is not interchangeable with mycophenolate mofetil without physician supervision due to differing absorption rates.
mycophenolic acid
(Mycophenolic Acid)
Biocon Pharma Inc.
Usage: Mycophenolic acid delayed-release tablets are indicated for the prophylaxis of organ rejection in adult and pediatric kidney transplant patients (5 years and older). They should be used alongside cyclosporine and corticosteroids, and not interchangeably with mycophenolate mofetil products without physician supervision.
prednisolone sodium phosphate
(Prednisolone Sodium Phosphate)
PAI Holdings, LLC
Usage: Prednisolone sodium phosphate oral solution is indicated for severe allergic conditions, dermatologic and endocrine disorders, gastrointestinal diseases, hematologic disorders, neoplastic diseases, acute multiple sclerosis exacerbations, ocular inflammation, respiratory diseases, rheumatic disorders, and specific miscellaneous conditions involving tuberculosis and organ rejection.
prograf
(Tacrolimus)
Astellas Pharma US, Inc.
Usage: PROGRAF® is indicated for the prophylaxis of organ rejection in adult and pediatric patients receiving allogeneic transplants of the kidney, liver, heart, or lung, as part of a regimen with other immunosuppressants.
sirolimus
(Sirolimus)
Ascend Laboratories, LLC
Usage: Sirolimus is indicated for the prophylaxis of organ rejection in renal transplant patients aged 13 and older, particularly in high-risk groups, and for the treatment of lymphangioleiomyomatosis (LAM). Its use involves specific combinations with cyclosporine and corticosteroids based on immunologic risk levels.
sirolimus
(sirolimus)
NorthStar RxLLC
Usage: Sirolimus tablets are indicated for the prophylaxis of organ rejection in renal transplant patients aged 13 and older and for treating lymphangioleiomyomatosis (LAM). In renal transplantation, dosing varies based on immunologic risk, with specific recommendations for combining with cyclosporine and corticosteroids.
zortress
(everolimus)
Novartis Pharmaceuticals Corporation
Usage: Zortress is indicated for the prophylaxis of organ rejection in adult kidney and liver transplant patients at low to moderate immunologic risk. It is used in combination with other immunosuppressants and corticosteroids, with recommended therapeutic drug monitoring for efficacy. Safety in certain populations is not established.

Medications for Graft Rejection

mycophenolic acid

mycophenolic acid

mycophenolic acid

prednisolone sodium phosphate

prograf

sirolimus

sirolimus

zortress